SSKN - Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment
- Strata Skin Sciences ( NASDAQ: SSKN ) on Monday announced the U.S. commercial launch of its acne treatment TheraClear X.
- Shares of the company soared ~18% after hours to $1.39.
- The company said the TheraClearX Acne Therapy System is engineered and indicated specifically for the treatment of acne and that treatments can be completed in 15 to 20 minutes and are pain-free.
- SSKN also said it was exploring strategic partners internationally for the system.
For further details see:
Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment